Helen M. Coley
- Molecular Biology top 5%
- Oncology top 2%
- Biomedical Engineering top 5%
- Materials Chemistry top 10%
- Cancer Research top 5%
- Co-authors
- Hilary ThomasTim CrookMichael HughesJohnjoe McFaddenFatima H. LabeedS. Ravi P. SilvaVera NevesElena Heister
- Topics
- Drug Transport and Resistance Mechanisms (16 papers)Cancer therapeutics and mechanisms (13 papers)Carbon Nanotubes in Composites (10 papers)
- Cited by
- OncologyBiomaterialsCancer Research
- Partner nations
- United KingdomFranceGreece
In The Last Decade
Helen M. Coley
77 papers receiving 3.8k citations
Hit Papers
Peers
Comparison fields: 5 of 133
- Molecular Biology 1.7k
- Oncology 1.4k
- Biomedical Engineering 924
- Materials Chemistry 529
- Cancer Research 443
Countries citing papers authored by Helen M. Coley
This map shows the geographic impact of Helen M. Coley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helen M. Coley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helen M. Coley more than expected).
Fields of papers citing papers by Helen M. Coley
This network shows the impact of papers produced by Helen M. Coley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helen M. Coley. The network helps show where Helen M. Coley may publish in the future.
Co-authorship network of co-authors of Helen M. Coley
This figure shows the co-authorship network connecting the top 25 collaborators of Helen M. Coley. A scholar is included among the top collaborators of Helen M. Coley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Helen M. Coley. Helen M. Coley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 14 | |
| 2 | 3 | |
| 3 | 49 | |
| 4 | 42 | |
| 5 | 11 | |
| 6 | Paclitaxel-resistant MCF-7 cells show a caspase-less phenotype but retain sensitivity to many anticancer agents | 1 |
| 7 | 18 | |
| 8 | 53 | |
| 9 | 22 | |
| 10 | The COX-2 inhibitor celecoxib and its use in the management of prostate cancer. | 1 |
| 11 | 92 | |
| 12 | 90 | |
| 13 | 33 | |
| 14 | Preparation and evaluation of N-acylated anthracycline analogues for radiolabelling with I-124 and Br-76 - potential radiotracers for in vivo assessment of multidrug resistance | 1 |
| 15 | Copper-64-diphosphine complexes: Potential PET tracers for the assessment of multi-drug resistance in tumors | 3 |
| 16 | 6 | |
| 17 | 7 | |
| 18 | 49 | |
| 19 | 56 | |
| 20 | 44 |
About Helen M. Coley
Helen M. Coley is a scholar working on Oncology, Structural Biology and Molecular Biology, having authored 78 papers that have together received 3.9k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (16 papers), Cancer therapeutics and mechanisms (13 papers) and Carbon Nanotubes in Composites (10 papers). The work is most often cited by research in Oncology (1.4k citations), Biomaterials (431 citations) and Cancer Research (443 citations). Helen M. Coley has collaborated with scholars based in United Kingdom, France and Greece. Frequent co-authors include Hilary Thomas, Tim Crook, Michael Hughes, Johnjoe McFadden, Fatima H. Labeed, S. Ravi P. Silva, Vera Neves, Elena Heister, Paul Workman and Peter R. Twentyman. Their work appears in journals such as Nucleic Acids Research, Journal of Clinical Oncology and ACS Nano.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.